Delivery Room Assistance With the Placental Circulation Intact (PCI-T)

June 4, 2024 updated by: Simone Pratesi, University of Florence

Delivery Room Assistance With the Placental Circulation Intact: Effects on Early Postnatal Adaptation and Outcome of Preterm Babies. Study Protocol for a Randomized Control Trial (the PCI-trial)

Preterm newborns receiving placental transfusion at birth (a volume of blood coming from the placenta towards the newborn till the cord is left unclamped) have better neonatal outcomes (in particular reduction of intraventricular hemorrhage all grade). The placental transfusion strategies performed in preterm babies at delivery have been delayed cord clamping and cord milking. Both experimental strategies do not explore the contribution of the start of breathing on placental transfusion, as performed in a small time frame (30-60 seconds for delayed clamping and less than 20 sec for cord milking). To assist the newborn bedside near to the delivering mother, leaving the cord unclamped, would allow to explore the contribution of breathing,both spontaneously started or assisted by initial steps in stabilization, on early postnatal adaptation.

The purpose of the present study is to assess the feasibility and effectiveness of delivery room assistance with the placental circulation intact in comparison to cord milking for improving outcomes in very preterm newborns.

Study Overview

Detailed Description

At delivery, if the cord is not clamped immediately, a volume of blood coming from the placenta continues to pass into the newborn: this placental transfusion ranges between 25 and 40 ml/kg body weight, depending on gestational age, timing of cord clamping, position of the infant at birth, onset of respirations, and administration of uterotonics to the mother. Recent research studies on animals have indicated a possible physiological role of placental transfusion in the first minutes of life, during the postnatal transition phase. During fetal life, oxygenated blood coming from the placenta through the umbilical vein largely reach the heart left ventricle through the foramen ovale. So, before birth, the placenta guarantees the left ventricle pre-load, thus maintaining cardiac output towards the aorta and epi-aortic vessels. At birth, if the cord is clamped immediately, left ventricle suddenly loose the source of its filling and the left ventricle preload becomes fully dependent on pulmonary veins return from the lungs. Pulmonary blood flow increases slowly after birth as the newly born starts breathing, in fact ventilation triggers the fall of pulmonary vascular resistances. The period between cord clamping and the onset of breathing has been indicated as "non respiring interval", when the newly born is no more receiving oxygenated blood from the placenta and not yet from the lungs. During this period, cardiac output is decreased, and hemodynamic fluctuations associated to reduced cerebral oxygenation have been demonstrated in animals. Otherwise, if the cord is maintained unclamped, blood coming from the placenta through the umbilical vein continues to fill left ventricle, while the onset of newborn's ventilation increases pulmonary blood flow and venous return. Thus, delaying cord clamping till after the start of breathing would maintain left ventricle pre-load unchanged, as demonstrated by the absence of hemodynamic fluctuations associated to reduced cerebral oxygenation in animal studies. These phenomena are probably responsible for the reduced incidence of intra-ventricular hemorrhage in babies receiving placental transfusion. Recent meta-analysis in preterm newborns demonstrated that delayed cord clamping is associated to improvement in cardiovascular stability and reduced need for inotropes, lower incidence of all grade intra-ventricular hemorrhage and necrotizing enterocolitis, lower oxygen requirement at 36 week of post-menstrual age, and less need for red blood cell transfusions, apparently without any severe short-term related morbidities or adverse effects; however, randomized trials have not yet investigated newly born infants requiring resuscitation. Placental transfusion in preterm babies may take longer, and may be incomplete if the cord is clamped within 30 to 90 seconds. This seems logical, as at term, two-thirds of the feto-placental circulation is in the infant, whilst below 30 weeks gestation, a greater proportion is in the placenta. Also, the umbilical vein is smaller than at term, and uterine contraction less efficient. Therefore, preterm babies who start breathing during a prolonged placental transfusion would probably receive the best benefits in terms of improved outcomes.

Cord milking (pinching the cord close to the mother and running the fingers towards the baby, usually 3 to 5 times) has been suggested for preterm births as a means to obtain a placental transfusion more rapidly. This procedure takes less than 20 seconds to be performed thus allowing a timely resuscitation of the newborn, in a standard setting, if needed. Cord milking over-rides the infant's physiological control of its own blood volume and blood pressure, however, and disrupts umbilical blood flow. Cord milking compared to immediate cord clamping has been recently associated in a systematic review and meta-analysis with some benefits (less oxygen requirement at 36w of gestation, and less IVH all grades) and no adverse effects in the immediate postnatal period in preterm infants less than 33 weeks of gestational age; however, further studies are warranted to assess the effect of cord milking on neonatal and long-term outcomes.

The hypothesis of the study is that to assist a preterm baby less than 30 weeks gestation with placental circulation intact allows a better postnatal adaptation and improves outcome in the neonatal period. For an ethical reason the control group will receive cord milking instead of immediate cord clamping, based on recently published results favoring cord milking in preterm babies.

The study has been designed as a two-phases study: phase 1 to assess the feasibility of the protocol (first 20 patients recruited) and phase 2 to compare the efficacy of delivery room assistance with placental circulation intact (with cord clamping at 3 minutes of life) versus cord milking for improving outcome in the neonatal period. To maximise efficiency of the planned full trial, phase 1 data would remain blind by allocated group and so would contribute to the sample size of the full trial. Recruitment of phase 1 was started on April 2016 and was completed on April 2017. Phase 1 of the study have reached the targets for feasibility. Recruitment of phase 2 (remaining 182 patients) is expected to be completed by the end of December 2018.

Study Type

Interventional

Enrollment (Actual)

212

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bari, Italy
        • UTIN-Neonatologia, Ospedale di Venere
      • Bologna, Italy
        • UOC di Neonatologia e TIN, Dipartimento Materno-Infantile, Ospedale Maggiore
      • Florence, Italy, 50139
        • Neonatal Intensive Care Unit, Department of Maternal and Infant Health, Careggi University Hospital
      • Milan, Italy
        • Neonatal Intensive Care Unit, IRCCS Cà Granda Foundation, Maggiore Policlinico Hospital
      • Monza, Italy
        • San Gerardo Hospital
      • Perugia, Italy
        • SC TIN-Neonatologia, Azienda Ospedaliera di Perugia
      • Rimini, Italy
        • SOD di Neonatologia dell'Ospedale Infermi di Rimini
      • Vicenza, Italy
        • UOC di Neonatologia e TIN, Azienda ULSS8 Berica

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 months to 6 months (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Preterm newborns with gestational age between 23+0 and 29+6 weeks
  • Informed consent available

Exclusion Criteria:

  • Major congenital malformation
  • Hydrops fetalis, placental abruption
  • Rh isoimmunization
  • Twin pregnancy
  • Absence of informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: placental circulation intact
preterm newborns assisted bedside with placental circulation intact
bedside assistance with placental circulation intact during first 3 minutes of life
Active Comparator: cord milking
preterm newborns who receive cord milking before assistance performed in a routine setting
neonatal assistance in a standard setting after cord milking (milking four times 20 cm of cord)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
reduction of incidence of severe intraventricular hemorrhage, chronic lung disease or mortality
Time Frame: up to 36 weeks of postconceptional age
The Outcome Measure is a composite of 3 main adverse events (severe intraventricular hemorrhage, chronic lung disease or mortality), that each patient may present or not present during the time frame. It is expected a reduction of the number of participants presenting with one or more of them. Severe intraventricular hemorrhage will be assessed by cerebral echography using Papile classification, chronic lung disease will be assessed using Jobe et al diagnostic criteria.
up to 36 weeks of postconceptional age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Simone Pratesi, MD, Careggi University Hospital, Florence, Italy
  • Study Director: Carlo Dani, MD, Careggi University Hospital, Florence, Italy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 9, 2016

Primary Completion (Actual)

July 7, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

January 26, 2016

First Submitted That Met QC Criteria

January 28, 2016

First Posted (Estimated)

February 2, 2016

Study Record Updates

Last Update Posted (Actual)

June 5, 2024

Last Update Submitted That Met QC Criteria

June 4, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 152-2014

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Placental Transfusion

Clinical Trials on placental circulation intact

Subscribe